Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13198 | 30090613 | Toxicol Res (Camb) | Role of xenobiotics in the induction and progression of fatty liver disease. | 2018 | Details |
| A13199 | 30089858 | Lab Invest | Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. | 2018 | Details |
| A13200 | 30089409 | Ann Clin Biochem | Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease. | 2018 | Details |
| A13201 | 30089269 | Cell Rep | Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis. | 2018 | Details |
| A13202 | 30087027 | Hepatobiliary Pancreat Dis Int | Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population. | 2018 | Details |
| A13203 | 30086995 | Psychosomatics | Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus. | 2018 | Details |
| A13204 | 30086613 | Clin Mol Hepatol | Recent research trends and updates on nonalcoholic fatty liver disease. | 2018 | Details |
| A13205 | 30085339 | Int J Mol Med | Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in adults with non‑alcoholic fatty liver disease. | 2018 | Details |
| A13206 | 30084737 | Thyroid | Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2018 | Details |
| A13208 | 30083134 | Front Endocrinol (Lausanne) | Association of Nonalcoholic Fatty Liver Disease With Osteoporotic Fractures: A Cross-Sectional Retrospective Study of Chinese Individuals. | 2018 | Details |
| A13209 | 30083132 | Front Endocrinol (Lausanne) | Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis. | 2018 | Details |
| A13210 | 30081580 | Nutrients | Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways. | 2018 | Details |
| A13211 | 30081348 | Stem Cell Res | Establishment and characterization of an iPSC line from a 58 years old high grade patient with nonalcoholic fatty liver disease (70% steatosis) with homozygous wildtype PNPLA3 genotype. | 2018 | Details |
| A13212 | 30080949 | Liver Transpl | Liver Transplantation and Bariatric Surgery: Timing and Outcomes. | 2018 | Details |
| A13213 | 30080818 | Transplantation | Should Patients With NAFLD/NASH Be Surveyed for HCC? | 2019 | Details |
| A13214 | 30079133 | World J Hepatol | Associations between nonalcoholic fatty liver disease and ischemic stroke. | 2018 | Details |
| A13215 | 30079055 | Front Microbiol | Genetically Obese Human Gut Microbiota Induces Liver Steatosis in Germ-Free Mice Fed on Normal Diet. | 2018 | Details |
| A13216 | 30077785 | Clin Gastroenterol Hepatol | Importance of Evaluating Cardiovascular Risk and Hepatic Fibrosis in Patients With Newly Diagnosed Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13217 | 30077664 | Surg Obes Relat Dis | Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score. | 2018 | Details |
| A13219 | 30077415 | Ultrasound Med Biol | The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease. | 2018 | Details |
| A13220 | 30076741 | J Surg Oncol | Lower expression of tumor microRNA-26a is associated with higher recurrence in patients with hepatocellular carcinoma undergoing surgical treatment. | 2018 | Details |
| A13222 | 30076407 | Sci Rep | Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis. | 2018 | Details |
| A13223 | 30075812 | BMC Res Notes | Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study. | 2018 | Details |
| A13224 | 30075518 | Medicine (Baltimore) | Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016. | 2018 | Details |
| A13225 | 30075104 | Am J Med | Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis. | 2018 | Details |
| A13226 | 30074820 | Br J Radiol | Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI. | 2018 | Details |
| A13227 | 30074574 | J Pediatr Gastroenterol Nutr | Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13228 | 30074500 | Curr Opin Endocrinol Diabetes Obes | Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction. | 2018 | Details |
| A13229 | 30073778 | J Diabetes | Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial. | 2018 | Details |
| A13230 | 30073766 | Diabetes Obes Metab | Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study. | 2018 | Details |
| A13231 | 30072152 | Int J Cardiol | Link between plasma trans-fatty acid and fatty liver is moderated by adiposity. | 2018 | Details |
| A13232 | 30072147 | J Am Soc Hypertens | Bidirectional association between nonalcoholic fatty liver disease and hypertension from the Dongfeng-Tongji cohort study. | 2018 | Details |
| A13233 | 30071394 | Stem Cell Res | Establishment and characterization of an iPSC line from a 35 years old high grade patient with nonalcoholic fatty liver disease (30-40% steatosis) with homozygous wildtype PNPLA3 genotype. | 2018 | Details |
| A13234 | 30071259 | Biochimie | Sphingolipid metabolism in non-alcoholic fatty liver diseases. | 2018 | Details |
| A13235 | 30070873 | Nutr Hosp | Vitamin D nutritional status and its relationship with metabolic changes in adolescents and adults with severe obesity. | 2018 | Details |
| A13236 | 30070714 | Hepatology | Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition. | 2018 | Details |
| A13237 | 30070430 | Mol Nutr Food Res | Soyasaponins Reduce Inflammation and Improve Serum Lipid Profiles and Glucose Homeostasis in High Fat Diet-Induced Obese Mice. | 2018 | Details |
| A13239 | 30068869 | Biol Pharm Bull | Molybdate Attenuates Lipid Accumulation in the Livers of Mice Fed a Diet Deficient in Methionine and Choline. | 2018 | Details |
| A13240 | 30068662 | Gut | Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. | 2018 | Details |
| A13241 | 30068362 | J Transl Med | MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits. | 2018 | Details |
| A13242 | 30068065 | Clin Mol Hepatol | The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study. | 2018 | Details |
| A13243 | 30067118 | J Med Food | Black Radish (Raphanus sativus L. var. niger) Extract Mediates Its Hepatoprotective Effect on Carbon Tetrachloride-Induced Hepatic Injury by Attenuating Oxidative Stress. | 2018 | Details |
| A13244 | 30066228 | Infection | Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. | 2018 | Details |
| A13245 | 30066148 | Diabetologia | Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial. | 2018 | Details |
| A13246 | 30065915 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. | 2018 | Details |
| A13247 | 30065651 | Front Pharmacol | A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis. | 2018 | Details |
| A13248 | 30065557 | World J Gastroenterol | Considerations for bariatric surgery in patients with cirrhosis. | 2018 | Details |
| A13249 | 30064987 | Gut | Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study. | 2018 | Details |
| A13250 | 30064623 | Ugeskr Laeger | [Treatment of non-alcoholic fatty liver disease]. | 2018 | Details |
| A13251 | 30063751 | PLoS One | Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD. | 2018 | Details |
| A13253 | 30063688 | Gastroenterol Nurs | NASH Syndrome: The Coming Epidemic. | 2018 | Details |
| A13254 | 30063256 | Hepatology | Dual-Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression. | 2018 | Details |
| A13255 | 30062524 | Eur Radiol | Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI. | 2018 | Details |
| A13256 | 30061575 | Nat Commun | Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis. | 2018 | Details |
| A13257 | 30060948 | Biochem Biophys Res Commun | Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD. | 2018 | Details |
| A13258 | 30060808 | Adv Cancer Res | Sphingolipids at the Crossroads of NAFLD and Senescence. | 2018 | Details |
| A13259 | 30060618 | Molecules | Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A13260 | 30060614 | Nutrients | French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES. | 2018 | Details |
| A13261 | 30060508 | Int J Mol Sci | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver. | 2018 | Details |
| A13262 | 30060507 | Nutrients | Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity. | 2018 | Details |
| A13263 | 30060482 | Nutrients | Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A13264 | 32186078 | J Tradit Chin Med | Effects of extracts from soothing-liver and invigorating-spleen formulas on the injury induced by oxidative stress in the hepatocytes of rats with non-alcoholic fatty liver disease induced by high-fat diet. | 2018 | Details |
| A13265 | 31949816 | Int J Clin Exp Pathol | HCMV-encoded IE2 promotes NAFLD progression by up-regulation of SREBP1c expression in UL122 genetically modified mice. | 2018 | Details |
| A13266 | 30060179 | J Clin Endocrinol Metab | Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes. | 2018 | Details |
| A13267 | 30059745 | J Am Coll Surg | Nonalcoholic Fatty Liver Disease as a High-Value Predictor of Postoperative Hyperglycemia and Its Associated Complications in Major Abdominal Surgery. | 2018 | Details |
| A13268 | 30059671 | Gastroenterology | GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13269 | 30059409 | J Glaucoma | Association Between Nonalcoholic Fatty Liver Disease and Intraocular Pressure in Korean Adults. | 2018 | Details |
| A13270 | 30058778 | Hepatol Res | Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers. | 2018 | Details |
| A13271 | 30057681 | Oxid Med Cell Longev | Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT. | 2018 | Details |
| A13272 | 30057598 | Gastroenterol Res Pract | Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13274 | 30056271 | Redox Biol | Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. | 2018 | Details |
| A13275 | 30055803 | Biochem Biophys Res Commun | Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway. | 2018 | Details |
| A13276 | 30055626 | Lipids Health Dis | Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system. | 2018 | Details |
| A13277 | 30054905 | FEBS Lett | Upstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating mTOR. | 2018 | Details |
| A13278 | 30054551 | Sci Rep | Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. | 2018 | Details |
| A13279 | 30053055 | J Clin Endocrinol Metab | CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte-Stellate Cell Crosstalk. | 2018 | Details |
| A13280 | 30052880 | Endocrinology | GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice. | 2018 | Details |
| A13281 | 30052309 | Diabetes Metab Res Rev | Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. | 2018 | Details |
| A13283 | 30051965 | Mol Nutr Food Res | Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet. | 2018 | Details |
| A13284 | 30051943 | Hepatol Res | Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial). | 2018 | Details |
| A13285 | 30051518 | Phytother Res | Effect of virgin avocado oil on diet-induced hypercholesterolemia in rats via 1 H NMR-based metabolomics approach. | 2018 | Details |
| A13286 | 30051131 | Food Funct | Sulfated polysaccharide from Enteromorpha prolifera increases hydrogen sulfide production and attenuates non-alcoholic fatty liver disease in high-fat diet rats. | 2018 | Details |
| A13287 | 30049593 | Surg Obes Relat Dis | In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. | 2018 | Details |
| A13288 | 30049586 | Bioorg Med Chem | Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors. | 2018 | Details |
| A13289 | 30049509 | Clin Res Hepatol Gastroenterol | Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study. | 2018 | Details |
| A13290 | 30048963 | Dig Dis | Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis. | 2018 | Details |
| A13291 | 30048367 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? | 2018 | Details |
| A13292 | 30047465 | Chin J Nat Med | Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics. | 2018 | Details |
| A13293 | 30047462 | Chin J Nat Med | Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats. | 2018 | Details |
| A13294 | 30045169 | J Clin Gastroenterol | Both WHR and FLI as Better Algorithms for Both Lean and Overweight/Obese NAFLD in a Chinese Population. | 2019 | Details |
| A13295 | 30044707 | Autophagy | Dynamic MTORC1-TFEB feedback signaling regulates hepatic autophagy, steatosis and liver injury in long-term nutrient oversupply. | 2018 | Details |
| A13297 | 30042872 | Am J Nucl Med Mol Imaging | Hepato-splenic axis: hepatic and splenic metabolic activities are linked. | 2018 | Details |
| A13298 | 30042736 | Front Endocrinol (Lausanne) | Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease. | 2018 | Details |
| A13299 | 30042691 | Front Physiol | Aquaglyceroporins: Drug Targets for Metabolic Diseases? | 2018 | Details |
| A13300 | 30042374 | Int J Mol Sci | Silibinin Ameliorates O-GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13301 | 30042157 | J Lipid Res | Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. | 2018 | Details |
| A13302 | 30042031 | Med Eng Phys | Role of acoustic radiation force impulse imaging elastography in the assessment of steatohepatitis and fibrosis in rat models. | 2018 | Details |
| A13303 | 30041934 | J Pediatr | Assessment of Nonalcoholic Fatty Liver Disease Progression in Children Using Magnetic Resonance Imaging. | 2018 | Details |
| A13304 | 30041922 | Acad Radiol | Evaluation on Heterogeneity of Fatty Liver in Rats: A Multiparameter Quantitative Analysis by Dual Energy CT. | 2018 | Details |
| A13305 | 30039136 | Food Funct | trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways. | 2018 | Details |